Seegene, Stock Price Down 1.61% at This Time... 293,991 Shares Net Bought by Individuals in Last 5 Days

As of 2:30 PM on the 26th, Seegene is trading at 122,300 KRW, down 1.61% from the previous day. The trading volume is 755,246 shares, which is about 84.07% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On February 25, Kim Choonghyun, a researcher at Mirae Asset Daewoo, stated, "Even after the end of COVID-19, Seegene's sales may increase due to respiratory, HPV, and women's health products from the expanded analytical equipment. However, there is concern about the decline in sales of COVID-19 diagnostic kits, which surged in 2020. The key is business diversification. Global in vitro diagnostic companies have completed their current business structures through M&A. Securing over 300 billion KRW in cash assets and hiring an M&A specialist executive is positive. If there is good news about COVID-19 kits and equipment sales or business diversification, earnings estimates could be revised upward." He set Seegene's target price at 188,000 KRW.

Over the past five days, individual investors have net purchased 293,991 shares of Seegene, while foreigners and institutions have net sold 281,061 shares and 40,381 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.